Clinic
Oak Orchard Community Health Center INC.
Oak Orchard Community Health Center INC. was paid $16.93M by Medicaid between Jan 2018 and Dec 2024, across 117 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 35% of everything it billed.
33Billing provider infoOAK ORCHARD COMMUNITY HEALTH CENTER INC.
BROCKPORT, NY 14420
BROCKPORT, NY 14420
33aNPI1598707812assigned 06/12/2006
33bProvider typeCommunity Health Clinic/Center
28Total paid$16.93M
24GClaims436,651
24DCodes billed117
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Community Health Clinic/Center providers in New York
Rank by total paid#5 of 29
Median peer was paid$569K
This provider vs. median30×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 43,673 | $1.85M | |
| 2019 | 52,321 | $2.08M | |
| 2020 | 55,238 | $1.55M | |
| 2021 | 62,223 | $1.78M | |
| 2022 | 43,600 | $2.14M | |
| 2023 | 97,162 | $3.90M | |
| 2024incomplete | 82,434 | $3.64M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35% | 136,863 | 75,705 | $5.96M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 73,607 | 36,578 | $3.46M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 9.6% | 21,169 | 9,844 | $1.63M |
| D1110 | Prophylaxis - adult | 5.0% | 21,065 | 10,064 | $852K |
| D0120 | Dental checkup, returning patientPeriodic oral evaluation - established patient | 2.3% | 11,841 | 7,707 | $391K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.3% | 13,469 | 4,822 | $388K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.1% | 16,039 | 4,381 | $364K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.6% | 12,512 | 12,184 | $266K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 1.6% | 2,992 | 1,386 | $264K |
| D1120 | Dental cleaning, childProphylaxis - child | 1.5% | 7,921 | 3,873 | $249K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 1.4% | 3,625 | 1,938 | $241K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.4% | 7,931 | 2,838 | $231K |
105 more codes
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 1.3% | 2,604 | $213K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.2% | 9,250 | $205K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.0% | 1,592 | $174K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 1,952 | $166K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 2,370 | $164K |
| D0330 | Panoramic radiographic image | <1% | 4,318 | $137K |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 3,320 | $112K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 1,246 | $110K |
| 96127 | <1% | 21,075 | $97K | |
| D0140 | Limited oral evaluation - problem focused | <1% | 2,335 | $84K |
| D0274 | Bitewings - four radiographic images | <1% | 3,279 | $76K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 4,929 | $75K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 1,193 | $68K |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | <1% | 1,524 | $65K |
| 99443 | <1% | 1,340 | $61K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,316 | $56K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,152 | $55K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 672 | $55K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 788 | $50K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 5,119 | $50K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 890 | $46K |
| D0220 | Intraoral - periapical first radiographic image | <1% | 1,829 | $41K |
| V2020 | Frames, purchases | <1% | 1,582 | $40K |
| D1206 | Topical application of fluoride varnish | <1% | 1,218 | $34K |
| 90686 | <1% | 3,887 | $33K | |
| 99442 | <1% | 1,028 | $31K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 551 | $25K |
| V2200 | Sphere, bifocal, plano to plus or minus 4.00d, per lens | <1% | 502 | $25K |
| D0210 | Intraoral - complete series of radiographic images | <1% | 568 | $19K |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 1,169 | $17K |
| 94760 | <1% | 1,116 | $17K | |
| D0272 | Bitewings - two radiographic images | <1% | 1,031 | $16K |
| 99441 | <1% | 527 | $14K | |
| 99406 | <1% | 956 | $14K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 853 | $13K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 186 | $13K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 254 | $13K |
| D9995 | <1% | 359 | $11K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 394 | $10K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,564 | $10K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 177 | $9K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 346 | $8K |
| 92551 | <1% | 878 | $8K | |
| 98968 | <1% | 144 | $7K | |
| D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | <1% | 121 | $6K |
| 0012A | <1% | 173 | $6K | |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 107 | $6K |
| 99188 | <1% | 679 | $6K | |
| G0467 | Community health center visit, returning patient | <1% | 359 | $5K |
| 99205 | Prolong outpt/office vis | <1% | 70 | $5K |
| 90682 | <1% | 80 | $5K | |
| 0011A | <1% | 157 | $4K | |
| D1351 | Sealant - per tooth | <1% | 112 | $4K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 61 | $4K |
| 99384 | <1% | 83 | $3K | |
| 99383 | <1% | 75 | $3K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 102 | $3K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 48 | $2K |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 117 | $2K |
| D0190 | <1% | 49 | $2K | |
| 0002A | <1% | 41 | $2K | |
| D1330 | <1% | 760 | $2K | |
| T2022 | Case management, per month | <1% | 13 | $1K |
| 90715 | <1% | 62 | $1K | |
| 99000 | <1% | 333 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 119 | $1K |
| 0071A | <1% | 27 | $988.10 | |
| 0001A | <1% | 24 | $928.74 | |
| S0580 | Polycarbonate lens (list this code in addition to the basic code for the lens) | <1% | 47 | $878.38 |
| 90656 | <1% | 422 | $818.72 | |
| V2784 | Lens, polycarbonate or equal, any index, per lens | <1% | 1,340 | $750.00 |
| 99408 | <1% | 215 | $611.85 | |
| 82948 | <1% | 54 | $593.62 | |
| 99051 | <1% | 42 | $589.62 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 155 | $577.81 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 236 | $562.14 |
| 83655 | <1% | 73 | $550.50 | |
| 90685 | <1% | 130 | $488.24 | |
| 0072A | <1% | 12 | $476.43 | |
| 99173 | <1% | 764 | $312.51 | |
| 90734 | <1% | 114 | $244.38 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 24 | $234.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 16 | $230.86 |
| 90670 | <1% | 256 | $226.32 | |
| 90648 | <1% | 225 | $192.43 | |
| 86580 | <1% | 15 | $180.11 | |
| 90688 | <1% | 75 | $173.86 | |
| 90633 | <1% | 164 | $163.44 | |
| 82465 | <1% | 28 | $117.28 | |
| 90723 | <1% | 103 | $108.96 | |
| 85018 | <1% | 63 | $79.48 | |
| 80061 | Lipid panel | <1% | 13 | $70.11 |
| 81002 | <1% | 117 | $59.09 | |
| 90461 | <1% | 199 | $58.66 | |
| 84703 | <1% | 13 | $16.69 | |
| 3078F | 0% | 46 | $0.00 | |
| 90710 | 0% | 12 | $0.00 | |
| 3074F | 0% | 131 | $0.00 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 93 | $0.00 |
| 90651 | 0% | 165 | $0.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 12 | $0.00 |
| 90680 | 0% | 49 | $0.00 | |
| D4999 | 0% | 12 | $0.00 | |
| 3079F | 0% | 13 | $0.00 | |
| 90619 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKINTER, KAREN (CEO)
| Provider | Location | Paid |
|---|---|---|
| Regional Health Reach INC. | Rochester, NY | $391K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.